Genetic testing has historically been associated with individuals who have a strong family history of disease or a known inherited condition. In many clinical settings, testing was initiated only after multiple cases of a condition appeared within a family. That model is beginning to shift. As testing becomes more accessible and awareness increases, genetic screening is being considered earlier and in broader populations. This is particularly relevant for hereditary cancers and recessive genetic conditions that may not present clearly through family history alone.
A key application of genetic testing is the identification of inherited cancer risk. Mutations in genes such as BRCA1 and BRCA2 are associated with significantly increased lifetime risk for cancers, including breast and ovarian cancer. These mutations can remain undetected in the absence of genetic testing, particularly in individuals without a well-documented family history. Early identification allows for changes in clinical management. Patients may begin screening at younger ages, increase the frequency of monitoring, or pursue additional preventive strategies based on individual risk profiles. Genetic testing does not establish certainty. Instead, it provides risk stratification, which can inform decision-making between patients and providers.
Access to genetic testing has traditionally been limited by logistical and systemic barriers. Referral requirements, limited availability of genetic specialists, and extended wait times for counseling have contributed to underuse. At-home testing models are helping address some of these challenges. Programs such as jscreen, a national nonprofit public health initiative, provide saliva-based collection kits that can be completed remotely, with results delivered within a defined timeframe and paired with access to licensed genetic counselors through telehealth. This model reduces barriers to entry while maintaining clinical support. The inclusion of counseling is particularly important, as genetic results can be complex and require careful interpretation.
In addition to cancer risk assessment, genetic testing plays a significant role in identifying carriers of inherited conditions. Carrier screening evaluates whether an individual carries a gene associated with a recessive disorder. Conditions commonly included in these panels include Tay-Sachs disease, cystic fibrosis, and sickle cell disease. Carriers are typically asymptomatic and, without testing, may be unaware of their status. When both partners carry the same gene, there is an increased risk of passing the condition to their children. Identifying carrier status prior to or during family planning allows individuals and couples to consider available options and consult with healthcare providers about next steps.
Genetic testing is most effective when paired with appropriate clinical guidance. Results can include variants of uncertain significance, elevated risk markers, or findings that require follow-up testing. Without proper interpretation, these results can lead to confusion or misinformed decisions. Genetic counselors provide context, helping patients understand the clinical relevance of their results. They also assist in determining whether additional screening, specialist referral, or changes in care are warranted. Given the current shortage of genetic counseling professionals in many regions, telehealth models have become an important component in expanding access to this support.
Genetic testing is not a replacement for standard preventive measures, but it is increasingly viewed as a complementary tool. Traditional screening methods detect disease at an early stage. Genetic testing shifts the focus further upstream, identifying risk before disease develops. This distinction allows for more personalized care strategies over time. For patients, integration often begins with reviewing family health history and discussing potential testing with a provider. Even in the absence of known risk factors, testing may provide useful information for long-term health planning. As preventive care continues to evolve, genetic testing is becoming a more routine consideration. Its value lies not only in identifying risk, but in enabling earlier, more informed decision-making across a range of health outcomes.
Photo by Omar Lopez.
